Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot Study: Iron-chelating treatment in patients with Neurodegeneration with Brain Iron Accumulation (NBIA)
2008-005206-39Phase 2Active
- Sponsor
- Ospedali Galliera
- Start
- Nov 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of deferiprone in Neurodegeneration with brain iron accumulation (NBIA), sponsored by Ospedali Galliera. Primary endpoints: Efficacy of deferiprone in NBIA and Tolerability of deferiprone. Started Nov 2008; status: active.
02
Drugs
deferiprone
03
Conditions
Neurodegeneration with brain iron accumulation (NBIA)
Beyond the preview
Go deeper on 2008-005206-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005206-39.